The cost-effectiveness of sun, sea and psoriasis

被引：0
|
作者：
Browne, R. [1 ]
Gee, B. [1 ]
机构：
[1] South Warwickshire NHS Fdn Trust, Warwick, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2017年 / 177卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P30
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF APREMILAST FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS IN GREECE
    Solakidi, A.
    Tzanetakos, C.
    Maniadakis, N.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A803 - A803
  • [22] Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis
    Hendrix, Nathaniel
    Ollendorf, Daniel A.
    Chapman, Richard H.
    Loos, Anne
    Liu, Shanshan
    Kumar, Varun
    Linder, Jeffrey A.
    Pearson, Steven D.
    Veenstra, David L.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (12): : 1210 - +
  • [23] COST-EFFECTIVENESS COMPARISON OF RISANKIZUMAB AND USTEKINUMAB FOR THE TREATMENT OF SEVERE PSORIASIS
    Dzik, M.
    Nadzieja-Koziol, A.
    Owczarek, W.
    [J]. VALUE IN HEALTH, 2019, 22 : S423 - S423
  • [24] Cost, Effectiveness, and Cost-Effectiveness
    Diamond, George A.
    Kaul, Sanjay
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (01): : 49 - 54
  • [25] ACCOUNTING FOR PARTIAL RESPONDERS IN COST-EFFECTIVENESS MODELING OF BIOLOGICS FOR PSORIASIS
    Sikirica, S.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A27 - A28
  • [26] COST-EFFECTIVENESS OF APREMILAST IN MODERATE-TO-SEVERE PSORIASIS IN CANADA
    Cawston, H.
    Damera, V
    Ektare, V
    Shear, N. H.
    Tencer, T.
    Liu, F. F.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A587 - A587
  • [27] Cost-effectiveness of biologic therapies for plaque psoriasis: A systematic review
    Ahn, Christine
    Gustafson, Cheryl
    Davis, Scott
    Feldman, Steven
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB2 - AB2
  • [28] Effectiveness of cost-effectiveness
    Huda, Ahmed S.
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2012, 200 (06) : 513 - 513
  • [29] WILL COST-EFFECTIVENESS ANALYSIS WORSEN THE COST-EFFECTIVENESS OF CARE
    HIMMELSTEIN, DU
    WOOLHANDLER, S
    BOR, DH
    [J]. CLINICAL RESEARCH, 1987, 35 (03): : A744 - A744
  • [30] Model to Determine the Cost-Effectiveness of Screening Psoriasis Patients for Psoriatic Arthritis
    Iragorri, Nicolas
    Hazlewood, Glen
    Manns, Braden
    Bojke, Laura
    Spackman, Eldon
    [J]. ARTHRITIS CARE & RESEARCH, 2021, 73 (02) : 266 - 274
12345